Your browser version may not work well with NCBI's Web applications. More information here...
1: Chir Ital. 1995;47(2):50-4.Links

[Resection surgery in malignant neoplasms of the exocrine pancreas: our experience, 1987-1994]

[Article in Italian]

Ghidoni S, Bruni T, Viotto A, Pulica C, Bruni O, Francia L, Tedoli M, Caleffi G, Busani M, Tenchini P.

I Divisione di Chirurgia Generale, Azienda Ospedaliera, Ospedale Carlo Poma, Mantova.

From 1987 to 1994, 24 patients underwent resection for pancreatic cancer; they represented 24% of all patients observed in that period. Surgical procedures were a pancreatoduodenectomy (PD) in 20 cases, a distal pancreatectomy in 4 cases, a palliative intervention in 61 cases, an exploratory laparotomy in 13 cases and a video laparoscopy in 2 cases. Adjuvant treatments were given in addition to resection in 20 patients. In the 20 patients undergoing PD, mortality was 20% and morbidity 20%. There was no mortality and no morbidity in distal pancreatectomy. The 1-year survival in pancreatoduodenectomy was 50% and 0% for distal pancreatectomy. Pancreatic resection, radical and palliative, whenever technically possible, represents the treatment of choice for pancreatic cancer.

PMID: 8768087 [PubMed - indexed for MEDLINE]